Other

Sacklers agree to new $6bn Purdue US settlement over opioids

The Sackler family will pay up to $6 billion to address damage linked to the US opioid crisis under an amended Purdue Pharma bankruptcy plan following an agreement with holdout states, according to a court filing Thursday.

Other

Purdue Pharma owners up opioid settlement offer to $6 bn

The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator.

Other

US moves to block Purdue Pharma opioid settlement

The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits.

Other

Purdue makes new offer to settle role in opioid crisis

US drugmaker Purdue Pharma filed a new bankruptcy plan that would see its founders the Sackler families pay an additional $1.5 billion to settle the company's role in the devastating opioid crisis that has killed half a million ...

page 2 from 4